A Spotlight on HCV and SARS-CoV-2 Co-infection and Brain Function

Overview

Journal Pharmacol Biochem Behav

Publisher Elsevier

Specialties Biochemistry
Pharmacology
Psychology
Social Sciences

Date 2022 May 13

PMID 35561837

Authors

Kate Shirley

Jennifer M Loftis

Affiliations

Soon will be listed here.

Citing Articles

Inflammatory and mental health sequelae of COVID-19.

Loftis J, Firsick E, Shirley K, Adkins J, Le-Cook A, Sano E Compr Psychoneuroendocrinol. 2023; 15:100186.

PMID: 37223650 PMC: 10191701. DOI: 10.1016/j.cpnec.2023.100186.

Risk Factors of Severe COVID-19: A Review of Host, Viral and Environmental Factors.

Zsichla L, Muller V Viruses. 2023; 15(1).

PMID: 36680215 PMC: 9863423. DOI: 10.3390/v15010175.

References

Gill K, Ghazinian H, Manch R, Gish R . Hepatitis C virus as a systemic disease: reaching beyond the liver. Hepatol Int. 2015; 10(3):415-23. PMC: 4819925. DOI: 10.1007/s12072-015-9684-3. View

Jarvis J, Casazza J, Stone H, Meintjes G, Lawn S, Levitz S . The phenotype of the Cryptococcus-specific CD4+ memory T-cell response is associated with disease severity and outcome in HIV-associated cryptococcal meningitis. J Infect Dis. 2013; 207(12):1817-28. PMC: 3654748. DOI: 10.1093/infdis/jit099. View

Loftis J, Huckans M, Ruimy S, Hinrichs D, Hauser P . Depressive symptoms in patients with chronic hepatitis C are correlated with elevated plasma levels of interleukin-1beta and tumor necrosis factor-alpha. Neurosci Lett. 2007; 430(3):264-8. PMC: 2342938. DOI: 10.1016/j.neulet.2007.11.001. View

Morin L, Savale L, Pham T, Colle R, Figueiredo S, Harrois A . Four-Month Clinical Status of a Cohort of Patients After Hospitalization for COVID-19. JAMA. 2021; 325(15):1525-1534. PMC: 7970386. DOI: 10.1001/jama.2021.3331. View

Ronderos D, Omar A, Abbas H, Makker J, Baiomi A, Sun H . Chronic hepatitis-C infection in COVID-19 patients is associated with in-hospital mortality. World J Clin Cases. 2021; 9(29):8749-8762. PMC: 8546815. DOI: 10.12998/wjcc.v9.i29.8749. View

Mazza M, De Lorenzo R, Conte C, Poletti S, Vai B, Bollettini I . Anxiety and depression in COVID-19 survivors: Role of inflammatory and clinical predictors. Brain Behav Immun. 2020; 89:594-600. PMC: 7390748. DOI: 10.1016/j.bbi.2020.07.037. View

Yarlott L, Heald E, Forton D . Hepatitis C virus infection, and neurological and psychiatric disorders - A review. J Adv Res. 2017; 8(2):139-148. PMC: 5272938. DOI: 10.1016/j.jare.2016.09.005. View

Xie J, Tong Z, Guan X, Du B, Qiu H . Clinical Characteristics of Patients Who Died of Coronavirus Disease 2019 in China. JAMA Netw Open. 2020; 3(4):e205619. PMC: 7148440. DOI: 10.1001/jamanetworkopen.2020.5619. View

Huckans M, Seelye A, Parcel T, Mull L, Woodhouse J, Bjornson D . The cognitive effects of hepatitis C in the presence and absence of a history of substance use disorder. J Int Neuropsychol Soc. 2009; 15(1):69-82. PMC: 2990957. DOI: 10.1017/S1355617708090085. View

10.

Yang A, Kern F, Losada P, Agam M, Maat C, Schmartz G . Dysregulation of brain and choroid plexus cell types in severe COVID-19. Nature. 2021; 595(7868):565-571. PMC: 8400927. DOI: 10.1038/s41586-021-03710-0. View

11.

Nickbakhsh S, Mair C, Matthews L, Reeve R, Johnson P, Thorburn F . Virus-virus interactions impact the population dynamics of influenza and the common cold. Proc Natl Acad Sci U S A. 2019; 116(52):27142-27150. PMC: 6936719. DOI: 10.1073/pnas.1911083116. View

12.

Tang S, Helmeste D, Leonard B . Inflammatory neuropsychiatric disorders and COVID-19 neuroinflammation. Acta Neuropsychiatr. 2021; 33(4):165-177. DOI: 10.1017/neu.2021.13. View

13.

Zignego A, Giannini C, Gragnani L, Piluso A, Fognani E . Hepatitis C virus infection in the immunocompromised host: a complex scenario with variable clinical impact. J Transl Med. 2012; 10:158. PMC: 3441205. DOI: 10.1186/1479-5876-10-158. View

14.

Guler-Margaritis S, Mercan-Stanciu A, Toma L, Rusie D, Isac T, Dodot M . COVID-19 Mid-term Impact on Hepatocellular Carcinoma in Patients With Hepatitis C Chronic Infection. In Vivo. 2021; 35(6):3377-3383. PMC: 8627777. DOI: 10.21873/invivo.12636. View

15.

Kehe J, Ortiz A, Kulesa A, Gore J, Blainey P, Friedman J . Positive interactions are common among culturable bacteria. Sci Adv. 2021; 7(45):eabi7159. PMC: 8570599. DOI: 10.1126/sciadv.abi7159. View

16.

Ibanez-Samaniego L, Rapado-Castro M, Cabrero L, Navarrete C, Garcia-Mulas S, Ahumada A . Hepatitis C eradication improves cognitive function in patients with or without cirrhosis: A prospective real-life study. Eur J Neurol. 2021; 29(2):400-412. DOI: 10.1111/ene.15138. View

17.

Chew K, Bhattacharya D . Virologic and immunologic aspects of HIV-hepatitis C virus coinfection. AIDS. 2016; 30(16):2395-2404. PMC: 6039386. DOI: 10.1097/QAD.0000000000001203. View

18.

Operskalski E, Kovacs A . HIV/HCV co-infection: pathogenesis, clinical complications, treatment, and new therapeutic technologies. Curr HIV/AIDS Rep. 2011; 8(1):12-22. PMC: 3035774. DOI: 10.1007/s11904-010-0071-3. View

19.

Graham E, Clark J, Orban Z, Lim P, Szymanski A, Taylor C . Persistent neurologic symptoms and cognitive dysfunction in non-hospitalized Covid-19 "long haulers". Ann Clin Transl Neurol. 2021; 8(5):1073-1085. PMC: 8108421. DOI: 10.1002/acn3.51350. View

20.

Perico L, Benigni A, Casiraghi F, Ng L, Renia L, Remuzzi G . Immunity, endothelial injury and complement-induced coagulopathy in COVID-19. Nat Rev Nephrol. 2020; 17(1):46-64. PMC: 7570423. DOI: 10.1038/s41581-020-00357-4. View